Emerging Agents in the Pipeline for Merkel Cell Carcinoma

2 Vues
administrator
administrator
07/17/23

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

  • Catégorie

Montre plus

Aucun commentaire trouvé

Commentaires de Facebook

Suivant